We first examined the anti-proliferative effect of various PPIs on two aggressive and highly metastatic breast cancer cells, 4T1 and TS/A, namely, Amiloride and Cariporide as NHE1 inhibitors and Lansoprazole and Esomeprazole as V-ATPase inhibitors. The gene discussed is SLC9A1; the disease is breast cancer.